Sugi Predict

Sugi Predict / Compounds / SCHEMBL2028236

SCHEMBL2028236

SCHEMBL2028236

O=C(O)CNC(=O)CNC(=O)CNC(=O)[C@@H](S)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 3/20 0.47
▸ MME P08473 6/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ECE1 P42892 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ NPEPPS P55786 1/20 0.46
▸ LMNA P02545 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ GPR139 Q6DWJ6 1/20 0.38
▸ ITGB3 P05106 1/20 0.38
▸ ITGB1 P05556 1/20 0.38
▸ ITGAV P06756 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7745199 1.00 ACE (0.47) ACEMMEALDH1A1KMT2AMAPT
SCHEMBL8595093 0.94 ACE (0.51) ACEMMEALDH1A1KMT2AMAPT
SCHEMBL9067648 0.88 ACE (0.46) ACEMMEALDH1A1KMT2AMAPT
SCHEMBL10720961 0.87 KMT2A (0.38) ACEMMEALDH1A1KMT2AMAPT
SCHEMBL9067650 0.85 ACE (0.40) ACEMMEALDH1A1KMT2AMAPT
SCHEMBL9067249 0.80 GPR139 (0.47) ACEMMEKMT2AMEN1GPR139
SCHEMBL8980460 0.76 KMT2A (0.46) ACEKMT2AMAPTMEN1HPGD
SCHEMBL8904451 0.76 MAPK1 (0.39) ACEMMEALDH1A1KMT2AMAPT
SCHEMBL7293621 0.75 KDM4E (0.59) KMT2AMAPTMEN1KDM4EGPR139
SCHEMBL7515133 0.75 KDM4E (0.59) KMT2AMAPTMEN1KDM4EGPR139

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1486509-A2 Radiolabeled annexin-galactose cluster conjugates NEORX CORPORATION (US) 2004-12-15 — — EP claimed
EP-0799050-B1 RADIOLABELED ANNEXIN-GALACTOSE CLUSTER CONJUGATES NEORX CORP (US) 2004-08-11 — — EP claimed
EP-0247866-B1 COUPLING AGENTS FOR RADIOLABELING PROTEINS Mallinckrodt, Inc. (a Delaware corporation) (US) 1990-11-14 — — EP claimed
US-12589171-B2 177-Lu labeled peptide for site-specific uPAR-targeting TRT INNOVATIONS APS (DK) 2026-03-31 — — US disclosed
US-20210236666-A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING RIGSHOSPITALET (DK) 2021-08-05 — — US disclosed
US-10994032-B2 177-Lu labeled peptide for site-specific uPAR-targeting TRT INNOVATIONS APS (DK) 2021-05-04 — — US disclosed
EP-2846826-B1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING TRT INNOVATIONS APS (DK) 2018-07-25 — — EP disclosed
US-9345789-B2 Specific inhibitors and active site probes for legumain THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2016-05-24 — — US disclosed
US-20150132219-A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING TRT INNOVATIONS APS (DK) 2015-05-14 — — US disclosed
EP-2846826-A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING Rigshospitalet RH (DK) 2015-03-18 — — EP disclosed
WO-2013167130-A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING RIGSHOSPITALET (DK) 2013-11-14 — — WO disclosed
US-5405597-A Reacting disulfide peptide under reducing condition to produce sulfhydryl form, reacting reduced peptide with prereduced technetium complex; used for radiological imaging DIATECH, INC. (US) 1995-04-11 — — US disclosed
US-5225180-A Technetium-99m labeled somatostatin-derived peptides for imaging DIATECH, INC. (US) 1993-07-06 — — US disclosed
EP-0248506-B1 METAL ION LABELING OF CARRIER MOLECULES Mallinckrodt, Inc. (a Delaware corporation) (US) 1992-08-12 — — EP disclosed
US-5082930-A Diagnosis, tumors MALLINCKRODT MEDICAL, INC. (US) 1992-01-21 — — US disclosed
EP-0247866-B1 COUPLING AGENTS FOR RADIOLABELING PROTEINS Mallinckrodt, Inc. (a Delaware corporation) (US) 1990-11-14 — — EP disclosed
US-4861869-A Coupling agents for joining radionuclide metal ions with biologically useful proteins MALLINCKRODT, INC. (US) 1989-08-29 — — US disclosed
US-4732974-A 4,5-DIHYDROXYL-M-BENZENEDISULFONIC ACID MALLINCKRODT, INC. (US) 1988-03-22 — — US disclosed
EP-0248506-A1 Metal ion labeling of carrier molecules Mallinckrodt, Inc. (a Delaware corporation) (US) 1987-12-09 — — EP disclosed
EP-0247866-A1 Coupling agents for radiolabeling proteins Mallinckrodt, Inc. (a Delaware corporation) (US) 1987-12-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589171-B2 177-Lu labeled peptide for site-specific uPAR-targeting LNPEP, XPNPEP2, PLAUR ACE 2906/4885MME 121/4885ALDH1A1 4614/4885
US-10994032-B2 177-Lu labeled peptide for site-specific uPAR-targeting PLAUR, PLAU, PROKR2 ACE 1358/4885MME 307/4885ALDH1A1 3710/4885
US-20210236666-A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING PLAUR, PLAU, PROKR2 ACE 1358/4885MME 307/4885ALDH1A1 3710/4885
US-20150132219-A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING PLAUR, PLAU, PROKR2 ACE 1358/4885MME 307/4885ALDH1A1 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.